ReviewCancer immunology, immunotherapy : CII2022

Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials.

Maria Ormhøj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.